- Home
- WRBY vs APLS Comparison
WRBY vs APLS Comparison
Compare WRBY & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRBY
- APLS
- Stock Information
- Founded
- WRBY 2010
- APLS 2009
- Country
- WRBY United States
- APLS United States
- Employees
- WRBY N/A
- APLS N/A
- Industry
- WRBY Ophthalmic Goods
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- WRBY Health Care
- APLS Health Care
- Exchange
- WRBY Nasdaq
- APLS Nasdaq
- Market Cap
- WRBY 2.1B
- APLS 2.2B
- IPO Year
- WRBY 2021
- APLS 2017
- Fundamental
- Price
- WRBY $21.73
- APLS $17.69
- Analyst Decision
- WRBY Buy
- APLS Buy
- Analyst Count
- WRBY 15
- APLS 19
- Target Price
- WRBY $23.33
- APLS $37.67
- AVG Volume (30 Days)
- WRBY 2.2M
- APLS 2.1M
- Earning Date
- WRBY 08-07-2025
- APLS 07-31-2025
- Dividend Yield
- WRBY N/A
- APLS N/A
- EPS Growth
- WRBY N/A
- APLS N/A
- EPS
- WRBY N/A
- APLS N/A
- Revenue
- WRBY $795,094,000.00
- APLS $775,839,000.00
- Revenue This Year
- WRBY $16.13
- APLS $1.01
- Revenue Next Year
- WRBY $13.87
- APLS $22.14
- P/E Ratio
- WRBY N/A
- APLS N/A
- Revenue Growth
- WRBY 13.94
- APLS 48.04
- 52 Week Low
- WRBY $12.46
- APLS $16.10
- 52 Week High
- WRBY $28.68
- APLS $42.47
- Technical
- Relative Strength Index (RSI)
- WRBY 58.96
- APLS 42.98
- Support Level
- WRBY $21.23
- APLS $18.26
- Resistance Level
- WRBY $22.43
- APLS $19.96
- Average True Range (ATR)
- WRBY 0.81
- APLS 0.84
- MACD
- WRBY -0.14
- APLS -0.08
- Stochastic Oscillator
- WRBY 48.15
- APLS 19.22
About WRBY Warby Parker Inc.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.